Alex Aravanis is the founder of Moonwalk Biosciences. Moonwalk Biosciences has raised $57M in total funding. Latest round: Series A.
Alex Aravanis, M.D., Ph.D., is a co-founder of Moonwalk Biosciences, a genomic medicine company focused on developing precision epigenetic medicines. The company recently launched with $57 million in seed and Series A financing. Moonwalk Biosciences utilizes a novel platform technology that provides a complete view of the epigenome and uses AI for target prediction, along with epigenetic engineering tools. Aravanis was formerly the CTO of Illumina.
Full founder directory · Investor directory · Company funding database · Fundraising library